Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer

Ahmet Murat Aydin1 Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA

Solomon L Woldu1 Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA

Ryan C Hutchinson1 Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA

Martin Boegemann2 Department of Urology, University of Münster Medical Center, Münster, Germany

Aditya Bagrodia1 Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA

Yair Lotan1 Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA

Vitaly Margulis1 Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA

Laura-Maria Krabbe1 Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA;2 Department of Urology, University of Münster Medical Center, Münster, GermanyCorrespondence[email protected]

show all

Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer

Articles from other publishers (9)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer

Citations (9)

Articles from other publishers (9)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date